BRPI0409767A - processo para a obtenção de guggulsterona e guggulsterol - Google Patents

processo para a obtenção de guggulsterona e guggulsterol

Info

Publication number
BRPI0409767A
BRPI0409767A BRPI0409767-0A BRPI0409767A BRPI0409767A BR PI0409767 A BRPI0409767 A BR PI0409767A BR PI0409767 A BRPI0409767 A BR PI0409767A BR PI0409767 A BRPI0409767 A BR PI0409767A
Authority
BR
Brazil
Prior art keywords
guggulsterone
formula
guggulsterol
obtaining
pregnadiene
Prior art date
Application number
BRPI0409767-0A
Other languages
English (en)
Inventor
Heonjoong Kang
Original Assignee
Heonjoong Kang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020030025904A external-priority patent/KR100639655B1/ko
Priority claimed from KR1020030025919A external-priority patent/KR100543533B1/ko
Priority claimed from KR1020030025936A external-priority patent/KR100543542B1/ko
Priority claimed from KR1020030025962A external-priority patent/KR100543544B1/ko
Priority claimed from KR1020030025989A external-priority patent/KR100543547B1/ko
Application filed by Heonjoong Kang filed Critical Heonjoong Kang
Publication of BRPI0409767A publication Critical patent/BRPI0409767A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005Ketals
    • C07J21/006Ketals at position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/005Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C07J33/007Cyclic thioketals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"PROCESSO PARA A OBTENçãO DE GUGGULSTERONA E GUGGULSTEROL". Refere-se a presente invenção a um método para a obtenção seletiva de 4,17 (20)-E-pregnadieno-3,16-diona (guggulsterona do tipo E) da fórmula (III) e 4,17 (20)-Z-pregnadieno-3,16-diona (guggulsterona do tipo Z) da fórmula (IV) que possuem o efeito de abaixar os níveis elevados da lipoproteína de baixa densidade (LDL) e os altos níveis de colesterol de maneira eficaz e elevar os níveis baixos da lipoproteína de alta densidade (HDL) a partir de um esteróide de fácil disponibilidade da fórmula (I). A presente invenção também proporciona um método para a obtenção do composto da fórmula (II).
BRPI0409767-0A 2003-04-24 2004-04-24 processo para a obtenção de guggulsterona e guggulsterol BRPI0409767A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR1020030025904A KR100639655B1 (ko) 2003-04-24 2003-04-24 16α,17α-에폭시프레그네놀론으로부터4,17(20)-프로스타디엔-3,16-디온의 제조방법 및 이를제조하기 위한 중간체
KR1020030025919A KR100543533B1 (ko) 2003-04-24 2003-04-24 5-안드로스텐-3β-올-17-온으로부터4,17(20)-프로스타디엔-3,16-디온의 제조방법 및 이를제조하기 위한 중간체
KR1020030025936A KR100543542B1 (ko) 2003-04-24 2003-04-24 4-안드로스텐-3,17-디온으로부터 구굴스테론의 제조방법및 이를 제조하기 위한 중간체
KR1020030025962A KR100543544B1 (ko) 2003-04-24 2003-04-24 테스토스테론으로부터 구굴스테론의 제조방법 및 이를제조하기 위한 중간체
KR1020030025989A KR100543547B1 (ko) 2003-04-24 2003-04-24 프로제스테론으로부터 구굴스테론의 제조방법 및 이를제조하기 위한 중간체
PCT/KR2004/000950 WO2004094450A1 (en) 2003-04-24 2004-04-24 Process for preparing guggulsterones and guggulsterol

Publications (1)

Publication Number Publication Date
BRPI0409767A true BRPI0409767A (pt) 2006-05-30

Family

ID=36479563

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409767-0A BRPI0409767A (pt) 2003-04-24 2004-04-24 processo para a obtenção de guggulsterona e guggulsterol

Country Status (9)

Country Link
US (1) US20070055072A1 (pt)
EP (4) EP2594577A1 (pt)
JP (2) JP4895804B2 (pt)
AT (1) ATE535538T1 (pt)
AU (1) AU2004232615B2 (pt)
BR (1) BRPI0409767A (pt)
CA (1) CA2523369C (pt)
ES (1) ES2376549T3 (pt)
WO (1) WO2004094450A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0409767A (pt) * 2003-04-24 2006-05-30 Heonjoong Kang processo para a obtenção de guggulsterona e guggulsterol
EP1886685A1 (en) * 2006-08-11 2008-02-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition
WO2008058156A2 (en) * 2006-11-06 2008-05-15 Jina Pharmaceuticals Inc. Guggulphospholipid methods and compositions
CN101195648A (zh) * 2007-12-03 2008-06-11 邵阳市科瑞化学品有限公司 制备二烯甾酮的方法
CN113082960B (zh) * 2021-04-09 2022-05-20 辽宁科技大学 一种宽温度窗口烟气脱硫用低共熔溶剂及生产、再生方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3141028A (en) * 1962-10-02 1964-07-14 Searle & Co 16-oxygenated pregna-4, 17(20)-[trans] dien-3-ones and intermediates thereto
IN167136B (pt) * 1988-05-04 1990-09-01 Cipla Ltd
EP0447706A1 (en) 1990-03-22 1991-09-25 Cipla Limited A process for the preparation of pharmacologically active synthetic z and e steroisomeric mixture of guggulsterones
DE4313089A1 (de) * 1993-04-22 1994-10-27 Basf Ag Verfahren zur Herstellung von 13-(Z)-Retinsäure
KR100446068B1 (ko) * 2001-10-23 2004-08-30 동방에프티엘 주식회사 구굴스테론의 제조방법
WO2004021975A2 (en) * 2002-09-03 2004-03-18 Ganga Raju Gokaraju An improved process for the synthesis of pharmacologically active (z/e)-guggulsterones
BRPI0409767A (pt) * 2003-04-24 2006-05-30 Heonjoong Kang processo para a obtenção de guggulsterona e guggulsterol

Also Published As

Publication number Publication date
EP1620455A1 (en) 2006-02-01
AU2004232615A1 (en) 2004-11-04
CA2523369A1 (en) 2004-11-04
US20070055072A1 (en) 2007-03-08
EP1620455B1 (en) 2011-11-30
JP4895804B2 (ja) 2012-03-14
JP2011157382A (ja) 2011-08-18
ATE535538T1 (de) 2011-12-15
EP2251346A3 (en) 2011-02-16
EP2284176A1 (en) 2011-02-16
EP2251346A2 (en) 2010-11-17
ES2376549T3 (es) 2012-03-14
JP2006524237A (ja) 2006-10-26
WO2004094450A1 (en) 2004-11-04
JP5430603B2 (ja) 2014-03-05
EP1620455A4 (en) 2009-08-05
AU2004232615B2 (en) 2007-05-24
EP2594577A1 (en) 2013-05-22
CA2523369C (en) 2009-08-04

Similar Documents

Publication Publication Date Title
IL145526A0 (en) Compositions and methods for effecting the levels of high density lipoprotein (hdl) chloesterol and apolipoprotein ai, very low density lipopritein (vldl) cholesterol and low density lipoprotein (ldl) cholesterol
WO2001077072A3 (en) Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality
WO2005062824A3 (en) Anti-hypercholesterolemic compounds
PE20030868A1 (es) Derivados de nicotinamida utiles como inhibidores de pde4
AU8016200A (en) Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
WO2004027822A3 (en) Oriented nanostructures and methods of preparing
WO2007027532A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
MXPA03007734A (es) Metodo para la busqueda de una guia de programas electronica.
WO2002046141A3 (en) Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
EP1511074A3 (en) A method for selective removal of high-K material
WO2006052555A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
WO2001072335A3 (en) Methods for effecting neuroprotection using a potassium channel modulator
WO2007044318A3 (en) Anti-hypercholesterolemic compounds
WO2002058734A3 (en) Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
WO2003039480A3 (en) Method of treating disorder related to high cholesterol concentration
BRPI0409767A (pt) processo para a obtenção de guggulsterona e guggulsterol
EP1422297A4 (en) METHOD FOR TESTING BRONCHIAL ASTHMA
EP1254662A3 (en) Methods and kits for treating depression or preventing deterioration of cognitive function
WO2007035478A3 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
WO2005115332A3 (en) Heat sterilization of glucocorticosteroids
WO2003020860A3 (en) Methods for treating deodorizer distillate
WO2004043456A8 (en) Cholesterol absorption inhibitors for the treatment of demyelination
SG108300A1 (en) Installing frame for installation of shaft equipment, installing lift with installing frame and method of installation of shaft equipment
AU1924301A (en) Method for operating an integrated point of presence server network
WO2003080778A3 (en) Methods for treating deodorizer distillate

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.